Videos

The push to get 3D echo into the congenital operating room
Nee Khoo, MBChB, director of the echocardiography lab at Canada's Stollery Children’s Hospital, explains the rapid adoption of pediatric 3D transesophageal echo.
Nuclear cardiology expands beyond perfusion imaging as it enters a new era
Beyond amyloidosis, nuclear cardiology is also increasingly used to image inflammation and infection in the myocardium, especially in diseases such as cardiac sarcoidosis and myocarditis.
How clinicians can combat health disparities in cardio-oncology
Researchers, for example, could improve disparities by performing their tests on more diverse groups of patients. Daniel Addison, MD, shared his perspective with Cardiovascular Business.
Advances in imaging could help predict, prevent heart attacks
Imagers can now identify vulnerable plaques that were once very challenging to find. The next steps include improving the screening process and determining which lesions need to be treated right away.
How PET is transforming cardiac nuclear imaging
"PET has changed the practice of nuclear medicine in general and I think it is going to revitalize the practice of cardiology," Marcelo Di Carli, MD, told Cardiovascular Business. He noted that more practices seem interested in implementing PET than ever before.

Dr. Nee Khoo, director of the echocardiography lab, Stollery Children’s Hospital, Edmonton, Canada, explains the rapidly growing adoption of pediatric 3D transesophageal echo (TEE) to not only preplan, but also guide and assess the results of congenital heart surgeries.

The push to get 3D echo into the congenital operating room

Nee Khoo, MBChB, director of the echocardiography lab at Canada's Stollery Children’s Hospital, explains the rapid adoption of pediatric 3D transesophageal echo.

Nuclear cardiology is entering a new era—one that goes well beyond the traditional focus on myocardial perfusion imaging. According to Marcelo Di Carli, MD, editor-in-chief of the Journal of Nuclear Cardiology and chief of the Division of Nuclear Medicine at Brigham and Women’s Hospital, the field is rapidly expanding into diagnosing and monitoring complex cardiac diseases such as amyloidosis, sarcoidosis, myocarditis, and cardiac infections.

Nuclear cardiology expands beyond perfusion imaging as it enters a new era

Beyond amyloidosis, nuclear cardiology is also increasingly used to image inflammation and infection in the myocardium, especially in diseases such as cardiac sarcoidosis and myocarditis.

Daniel Addison, MD, Director of Translational Research in the Cardiology Division and Associate Director for Survivorship and Outcomes Research in the Harold C. Simmons Comprehensive Cancer Center. He also holds the Audre and Bernard Rapport Endowed Chair in Cardiovascular Research, UT Southwestern Medical Center. explains the health disparities and inequities involved in cardio-oncology.

How clinicians can combat health disparities in cardio-oncology

Researchers, for example, could improve disparities by performing their tests on more diverse groups of patients. Daniel Addison, MD, shared his perspective with Cardiovascular Business.

James Muller, MD, explains advances in vulnerable plaque imaging aim to predict and prevent heart attacks.

Advances in imaging could help predict, prevent heart attacks

Imagers can now identify vulnerable plaques that were once very challenging to find. The next steps include improving the screening process and determining which lesions need to be treated right away.

Marcelo Di Carli, MD, editor-in-Chief of the Journal of Nuclear Cardiology, chief, Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, and executive director, Cardiovascular Imaging Program, at Brigham and Women's Hospital, explains why there is rapid growth of PET imaging because of the extra value it brings in detecting microvascular disease.

How PET is transforming cardiac nuclear imaging

"PET has changed the practice of nuclear medicine in general and I think it is going to revitalize the practice of cardiology," Marcelo Di Carli, MD, told Cardiovascular Business. He noted that more practices seem interested in implementing PET than ever before.

Ismail El-Hamamsy, MD, PhD, director of aortic surgery for the Mount Sinai Health System, explains the long-term outcomes of the Ross procedure, where a diseased aortic valve is surgically replaced with the patient's own pulmonary valve.

Long-term data highlight Ross procedure's safety, effectiveness in younger patients

TAVR may get more attention, but the Ross procedure has also gained significant momentum in recent years. Ismail El-Hamamsy, MD, PhD, detailed his own team's success with the complex procedure.

David Magid, MD, MPH/MSPH, a professor of cardiology at the University of Colorado, explains attributing cardiac patient care to physicians in accountable care organizations.

Common methods for attributing cardiac care in ACOs may be falling short

As the United States continues to move toward quality-based care, ACOs need to rethink the way they attribute care to cardiologists and other members of the heart team.

As cancer therapies become increasingly targeted and complex, the need for sophisticated cardiovascular monitoring has grown in parallel. Cardiovascular Business spoke with Daniel Addison, MD, director of the cardio-oncology program at The Ohio State University and chair of the American Heart Association’s (AHA) Cardiac Imaging Committee, who said the use of multimodality imaging is transforming how clinicians manage cardiovascular risk in cancer patients and survivors.

Multimodality imaging is more important than ever to the field of cardio-oncology

“Multimodality imaging in cardio-oncology is something many of us in the field are truly excited about," Daniel Addison, MD, told Cardiovascular Business. He noted that modalities other than echocardiography are starting to play a much larger role in the treatment of these patients.